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Abstract 
Objective: The purpose of this study was to investigate whether and how vagus nerve 
stimulation (VNS) reduces the epileptogenic activity in the bilateral cerebral cortex in 
patients with intractable epilepsy. 
Method: We analyzed the electrocorticograms (ECoGs) of five patients who underwent 
callosotomy due to intractable epilepsy even after VNS implantation. We recorded ECoGs 
and analyzed power spectrum in both VNS OFF and ON phases. 
Results: We counted the number of spikes and the number of electrodes with epileptic 
spikes, distinguishing unilaterally hemispherically spread and bilaterally hemispherically 
spread spikes as synchronousness of the epileptic spikes in both VNS OFF and ON phases. 
There were 24.80 ± 35.55 and 7.20 ± 9.93 unilaterally spread spikes in the VNS OFF and 
ON phases, respectively (p = 0.157), and 35.8 ± 29.21 and 10.6 ± 13.50 bilaterally spread 
spikes in the VNS OFF and ON phases, respectively (p = 0.027). The number of 
electrodes with unilaterally and bilaterally spread spikes in the VNS OFF and ON phases 
was 3.84 ± 2.13 and 3.59 ± 1.82 (p = 0.415), and 8.20 ± 3.56 and 6.89 ± 2.89 (p = 0.026), 
respectively. The ECoG background power spectra recordings in the VNS OFF and ON 
phases were also analyzed. The spectral power tended to be greater in the high-frequency 
band at VNS ON phase than OFF phase. 
Conclusion: This study showed the reduction of epileptogenic spikes and spread areas of 
the spikes by VNS as immediate effects, electrophysiologically.  
Introduction 
Vagus nerve stimulation (VNS) is a palliative therapy for drug-resistant, intractable 
epilepsy that restrains an epileptic seizure by providing intermittent electric stimulations 
to the cervical vagus nerve. The clinical application of VNS was started based on the 
fundamental researches in an animal model in the United States in 1988, and health 
insurance coverage for VNS was applicable in Japan in 20101,2). Several large clinical 
trials have demonstrated the results of VNS; thus, there is no room for doubt in terms of 
its effectiveness in the treatment of intractable epilepsy3,4). In addition, improvement of 
the cognitive function and emotional disorder has been known as a parallel effect 
associated with the restraint of epileptic seizures using VNS5). VNS has been used in 
clinical practice for the treatment of refractory depression since it was approved by the 
Food and Drug Administration (FDA) in the United States in 2005. Furthermore, it has 
been suggested as a treatment option for chronic migraine6,7) and the aftereffects of 
cerebral infarction due to its anti-inflammatory action; therefore, VNS should be applied 
in the treatment of more diseases in the future8,9). 
The responder ratio of the VNS treatment is 25, 37, and 50% at 3 months, 1 year, and 5 
years during a treatment period, respectively10,11). 
Although the mechanisms of the VNS treatment are still unclear, it has been suggested 
that its long-term effect is due to the modification of the extensive cerebrocortical 
activation by the deep brain nuclei, such as the thalamus, through the neurotransmitters, 
including the noradrenaline system12-14). However, few studies have been performed to 
analyze the immediate effect of VNS on the brain. It has been suggested in a prior study 
that the effect of VNS was associated with a direct or indirect influence on the 
electrophysiological modulation and/or the broad spread of the epileptogenic activity, 
from the nuclei of the solitary tract to the bilateral cortices in the acute phase15,16). In this 
study, we analyzed and compared the electrocorticogram changes before and after VNS 





The study subjects were five patients with intractable epilepsy who underwent an 
additional craniotomy (callosotomy) as a multistage-palliative treatment in our 
department between 2014 and 2018 because the effect of the preceded VNS therapy was 
insufficient or their satisfaction was poor. There were three males and two females, with 
an age range between 14 and 39 years (mean 26.2). These five patients were all poor-
responder of VNS therapy. The patients’ characteristics are summarized in Table 1. The 
mean period between the VNS surgery and callosotomy was 35 months. 
This study was approved by the Ethical Committee of Sapporo Medical University 
Graduate School of Medicine, and written informed consent was obtained from all 




All patients were administered general anesthesia by anesthesiologists, with the end-tidal 
sevoflurane concentration maintained at 2% during the electrocorticogram (ECoG) 
recording. The ECoG data were recorded using an MEE-1232 machine (Nihon Kohden, 
Tokyo, Japan), using a preamplifier bandwidth of 0.5-100 Hz and a sampling rate of 500 
Hz. Two 1×6 or 2×8 subdural electrodes grids (10 mm intercontact distance, each contact 
distant with 3 mm diameter [Unique Medical, Tokyo, Japan]) were placed on the bilateral 
frontal cortices intraoperatively (Figure 1); the reference electrode was placed on the 
earlobe, and the earth electrode was placed on the nasion. To precisely differentiate the 
VNS OFF and ON phases, an electrocardiogram was recorded at the same time to capture 
the stimulation artifact. During the VNS ON phases, the stimulation was associated with 
a 30 Hz activity detected on the electrocardiogram (Figure 2). 
The ECoG recordings consisted of discontinuous 180 seconds added consecutive 60 
seconds three times each in the VNS ON and OFF phases before the start of the corpus 
callosotomy. A normal mode of VNS was turned off before the operations, and only a 
magnet mode was used for the recordings in the VNS ON phases, of which duration was 
60 seconds. In order to avoid the influence of the VNS, the ECoG recordings were 
performed at least 60 seconds apart from the stimulation during the VNS OFF phases. In 
each patient, the usual VNS parameters were recorded (Table 1). 
 
ECoG Analysis 
The records were reviewed and annotated by two neurosurgeons, board-certified 
members of the Japanese Epilepsy Society, who were blinded to the VNS ON and OFF 
phases. We analyzed the spikes that they both matched and excluded the ones with an 
amplitude of less than 400 μV. We counted a spike and wave complex as one spike. 
We analyzed the number of spikes, the maximum amplitude of the spikes, and the number 
of electrodes where the spikes were shown. The power spectrum was then analyzed and 
compared between the VNS OFF and ON phases. The power spectrum was calculated by 
a fast Fourier transform range 1-60 Hz using MATLAB (Mathworks, Natick, 
Massachusetts, USA), and the number of points in the fast Fourier transform was 
configured to 500. We used all the electrodes of each patient for this analysis except ones 
containing artifacts or noise obviously caused by electronic devices and motion. 
 
Statistical Analysis 
The data are expressed as means ± standard deviations. We used the Wilcoxon paired 
samples test to identify the group differences. Repeated measure analysis of variance was 
used to analyze the spectral power in each frequency. 
All statistical analyses were conducted using the SPSS software package (version 12) 






We observed five consecutive patients with intractable epilepsy despite multiple anti-
epileptic drugs and even VNS implantation, who were scheduled to undergo callosotomy 
in our institution. The subjects’ age ranged between 14 and 39 years (mean 26.2).  
All patients were diagnosed with a generalized onset as seizure type and generalized 
epilepsy as epilepsy type, according to the International League Against Epilepsy (ILAE) 
classification of the epilepsies 201717,18). The seizure types in all patients are described in 
Table 1, as follows: generalized atonic (GA), generalized myoclonic (GM), and 
generalized tonic-clonic (GTC) in case 1; GA and GTC in case 2; focal impaired 
awareness (FIA), GA, and psychogenic non-epileptic (PNE) in case 3; and FIA, GA, and 
GTC in case 4 and 5. The epilepsy types were West syndrome (WS) and Lennox-Gastaut 
syndrome (LGS) in case 1, LGS in case 2, 3, and 4, and unknown in case 5; McHugh 
Classification class III in case 1, 2, and 5, and class II in case 3 and 4 (Table 1). 
In all cases, except for case 1, the frequency of the seizure attacks (FSA) had dramatically 
decreased soon after VNS implantation; however, after one to two years, the FSA 
gradually increased and the symptoms deteriorated. In case 1, although the complex 
seizure attacks had decreased after the VNS implantation, the drop attack had not 
decreased. Accordingly, the patients were scheduled to undergo callosotomy 23 to 63 
months after the VNS implantation.  
 
ECoGs Recordings 
During the callosotomy, we evaluated and compared the ECoGs between the VNS OFF 
 
and ON phases using subdural electrodes on both sides of the brain. The mean values of 
each of the following parameters VNS OFF phases versus ON phases, respectively. We 
counted the number of spikes, distinguishing the unilaterally hemispherically spread and 
the bilaterally hemispherically spread spikes as synchronousness of the epileptic spikes 
in both the VNS ON and OFF phases.  
The number of unilaterally spread spikes in the VNS OFF and ON phases was 2-78 (mean 
24.80 ± 35.55) and 0-23 (mean 7.20 ± 9.93), respectively; the difference was not 
statistically significant (p = 0.157). In contrast, the number of bilaterally spread spikes in 
the VNS OFF and ON phases was 5-83 (mean 35.8 ± 29.21) and 1-34 (mean 10.6 ± 13.50), 
respectively; the difference was statistically significant (p = 0.027). 
The number of electrodes with unilaterally spread spikes in the VNS OFF and ON phases 
was 1-13 (mean 3.84 ± 2.13) and 1-8 (mean 3.59 ± 1.82), respectively; the difference was 
not statistically significant (p = 0.415). In contrast, the number of electrodes with 
bilaterally spread spikes was 2-18 (mean 8.20 ± 3.56) and 2-15 (mean 6.89 ± 2.89) in the 
VNS OFF and ON phases, respectively; the difference was statistically significant (p = 
0.026). 
The maximum amplitude (mV) of the unilaterally spread spikes in the VNS OFF and ON 
phases was 0.41-1.72 (mean 1.03 ± 0.27) and 0.41-1.58 (mean 1.06 ± 0.24), respectively; 
  
the difference was not statistically significant (p = 0.391). The maximum amplitude (mV) 
of the bilaterally spread spikes in the VNS OFF and ON phases was 0.42-1.88 (mean 1.04 
± 0.33) and 0.42-1.58 (mean 0.99 ± 0.30), respectively; the difference was also not 
statistically significant (p = 0.438). A significant reduction in both the number of spikes 
and electrodes were shown in the VNS ON phases. This effect was more pronounced for 
the bilaterally than for the unilaterally spread spikes (Table 2). 
The ECoG background power spectra recordings were also analyzed in the VNS ON and 
OFF phases. We classified the frequency bands as delta: 1 to 3 Hz, theta: 4 to 7 Hz, alpha: 
8 to 13 Hz, beta: 14 to 30 Hz, and gamma: more than 31 Hz. The mean values of each 
spectral band in the VNS OFF and ON phases were as follows: Delta, 0.13 ± 0.45 and 
0.12 ± 0.44 (p = 0.002); Theta, 0.58 ± 0.20 and 0.57 ± 0.17 (p = 0.920); Alpha, 0.41 ± 
0.25 and 0.43 ± 0.21 (p = 0.068); Beta, 0.066 ± 0.0702 and 0.078 ± 0.075 (p < 0.001); 
and Gamma, 0.0041 ± 0.0053 and 0.0059 ± 0.0078, respectively (p < 0.001) (Figure 3). 
The spectral power tended to be greater in the high-frequency bands and in the VNS ON 
phases. VNS may induce an increase of the spectral power in the high-frequency bands, 





Vagus nerve stimulation (VNS) is a palliative therapy for refractory epilepsy that restrains 
an epileptic seizure by providing intermittent electric stimulations to the cervical vagus 
nerve. The aim of this study was to evaluate the effectiveness of VNS for suppression of 
the epileptic seizure using electrocorticography with subdural electrodes. Previous studies 
have analyzed the effect of VNS using EEG on the scalp, and demonstrated a decrease in 
the epileptic spikes and de-synchronousness as a long-term effect of VNS19-21). 
As stated above, the mechanisms of the epileptic seizure suppression with VNS is unclear. 
Various possibilities have been suggested, such as the change in the neurotransmitters’ 
concentration22-24), expression of a new protein25,26), and change in the local brain blood 
flow27-29). Most of the previous studies demonstrated the VNS long-term effects using the 
trans-scalp EEG recording19-21). Bartolomei et al. reported an evaluation with an 
intracranial electrode for the first time using stereotactic electroencephalography (SEEG), 
and mentioned the possibility that the functional connectivity between the corticocortical 
neurons may be changed by VNS30). Although subdural electrocorticography has many 
advantages including the sensitivity, preciseness, and spatial resolution, there are also 
some disadvantages compared to the transcranial electroencephalography, such as 
invasiveness and area coverage31-32). Some recent studies have reported on a non-invasive 
 
stimulation of other cranial nerves, such as trigeminal nerve stimulation33) and that 
percutaneous VNS could have effects similar to those of the conventional VNS34,35). 
In this study, interestingly, the VNS effects of decreased epileptic spikes and spread area 
were more pronounced in the bilaterally spread spikes than in the unilaterally spread 
spikes. Previous studies have suggested that patients with generalized seizure subtypes 
improved better in response to VNS than those with focal seizures36-39). Moreover, the 
seizure-free rate in patients undergoing VNS therapy was also described to be higher in 
the patients with primarily generalized seizures36). Although it is not fully understood 
why the VNS effects are more pronounced in patients with generalized than in those with 
focal seizures, our data might provide one explanation for it. Some authors showed that 
VNS may induce a decrease in the synchronization of the epileptic spikes19,40-42). This 
suggests that our findings can support the results of the past studies. 
The spectral power tended to be greater in the high-frequency bands in the VNS ON 
phases than in the VNS OFF phases. This power spectral finding suggests that the frontal 
cortex cells were electro-neurophysiologically affected by VNS. Gamma activity has 
previously been found to be increased in patients with epilepsia43,44). 
According to past reports, the action potential caused by the electrical stimulation of the 
vagus nerve is conducted afferently to the cerebral cortex through the nuclei of the solitary 
 
tract of the brainstem, suppressing the cerebrocortical electric activity in both sides 
through the thalamus, limbic system, putamen, and other regions45,46). Notably, in this 
study, we found a reduction of the epileptogenic spikes in the inter-ictal phases in both 
hemispheres as an immediate effect of VNS using the subdural electrodes. Because the 
VNS effect in this study occurred soon after its activation as an immediate effect, the 
electrophysiological mechanism may have directly or indirectly affected the cerebral 
cortex, which was supported with the electrocorticograms. 
 
The limitations of this study are as follows. First, all subjects were clinically non- or poor-
responders to VNS because of the study design. The mechanism of the VNS effect may 
be further elucidated by evaluating patients who respond to VNS using an 
electrocorticogram analysis. Second, the electrocorticography evaluation could be 
performed for only a short period and in a limited area. An evaluation of a broader area 
of the cortex can provide a more precise analysis in terms of the epileptic seizures’ spread 
in the brain. Finally, in this study, we could compare the profiles of the epileptogenic 
spikes in both the VNS OFF and ON phases only during the inter-ictal phases. It is much 
more important to evaluate the spikes in the ictal phases; however, that was impossible to 
do during the craniotomy surgery.   
 
We would like to emphasize that the results of this study proved the hypothesis that VNS 




In this study, we found that VNS induced a reduction in the epileptogenic spikes and the 
spread areas of the spikes in the inter-ictal period as immediate effects, which suggested 
that VNS can restrain the neurophysiologic activity of an abnormal epilepsy-related 
network in the cerebral cortex through the nuclei of the solitary tract even in non- or poor-
responding patients. Nonetheless, further investigation is necessary. 
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Table/Figure Legends 
Table 1. Patients’ characteristics. 
GA, generalized atonic; GM, generalized myoclonic; GTC, generalized tonic-clonic; FIA, 
focal impaired awareness; PNE, psychogenic non-epileptic; LGS, Lennox-Gastaut 
syndrome. 
CBZ, clobazam; CZP, clonazepam; ESM, ethosuximide; LEV, levetiracetam; LTG, 
lamotrigine; PB, phenobarbital; PHT, phenytoin; TPM, Topiramate; VPA, valproic acid; 
ZNS, zonisamide. 
 
Table 2. The difference among the five cases in the number of spikes, the maximum 




A: An intraoperative factual image of case 4. Two 2×8 subdural electrodes grids were 
placed on the bilateral frontal cortices. 




An example of ECoG recordings of the bilateral hemispheres in case 3 during the VNS 
ON and OFF phases. The artifact of VNS stimulation is recorded on the ECG during the 
VNS ON phases. The unilateral spikes were defined as discharges spreading unilaterally 
hemispherically (black arrowhead), and also the bilateral spikes were defined as 




A: The mean electrocorticographic spectral power in the VNS OFF phases (solid line) 
and VNS ON phases (dotted line). In the VNS ON phases, the high-frequency spectral 
power, including beta and gamma bands, was greater than in the VNS OFF phases. Power 
spectrum (µV2log) 
B: Power spectra of delta, theta, alpha, beta, and gamma bands in the frontal lobe before 
and after VNS. Power spectrum (µV2/s ± SD)  
Statistical significance: *p < 0.05 
Table 1 
Case Age, Gender Seizure type Epilepsy 
type 





(intensity, pulse width) 
Magnet mode parameters 
(intensity, pulse width, on time) 
1 17y, Male GA, GM, GTC LGS rt. temporal tumor 
polymicrogyria 
ESM, VPA, ZNS,  ClassⅢ 29 
months 
2.0mA, 500μs 2.25mA, 750μs, 60sec 
2 14y, Female GA, GTC LGS cortical dysplasia CBZ, CZP, LEV, TPM ClassⅢ 33 
months 
2.0mA, 750μs 2.25mA, 750μs, 60sec 
3 33y, Female FIA, GA, PNE LGS cortical dysplasia LEV, PHT, TPM, VPA ClassⅡ 26 
months 
2.25mA, 500μs 2.5mA, 500μs, 60sec 
4 28y, Male FIA, GA, GTC LGS viral infection PB, PHT, VPA ClassⅡ 23 
months 
2.0mA, 750μs 2.25mA, 750μs, 60sec 
5 39y, Male FIA, GA, GTC unknown none CZP, LEV, LTG ClassⅢ 63 
months 
1.625mA, 500μs 1.875mA, 750μs, 60sec 
Table 2 





unilateral bilateral  unilateral bilateral  unilateral bilateral  unilateral bilateral  unilateral bilateral 
                  
Number of spikes (n) 
 OFF  32 2  38 2  21 8  83 78  5 34 
 ON  7 0  9 0  1 2  34 23  2 11 
                  
Number of electrodes (n) 
(mean±SD) 
 OFF  3.1±1.2 9.5±1.5  2.7±1.5 4.5±0.50  3.9±1.9 12±2.7  4.7±2.3 8.0±3.4  2.6±1.0 7.9±3.8 
 ON  1.6±0.73 0  4.0±1.5 0  8.0±0 10±1.0  3.8±1.6 6.0±1.6  2.5±0.50 8.2±4.0 
                  
Maxium amplitude of spikes (mV) 
(mean±SD) 
 OFF  0.70±0.12 0.95±0.25  1.2±0.16 1.3±0  1.1±0.33 1.5±0.39  1.1±0.12 1.2±0.16  0.43±0.014 0.59±0.098 
  ON   0.75±0.13 0   1.3±0.093 0   1.6±0 1.3±0.30   1.2±0.12 1.1±0.13   0.45±0.035 0.60±0.11 
A B
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